5 Best Nanotechnology Stocks to Buy Now

2. Thermo Fisher Scientific Inc. (NYSE:TMO)

Hedge Fund Holdings: 92

Based in Waltham, Massachusetts, Thermo Fisher Scientific Inc. (NYSE:TMO) is an American supplier of scientific instrumentation, reagents, consumables, and software services.  The company is a market leader in nanoparticle research. Furthermore, the company’s Avizo Software allows for on-the-fly processing of statistics such as size, surface area, perimeter, distribution, and chemical composition of nanoparticles. Thermo Fisher Scientific Inc. (NYSE:TMO) posted an EPS of $5.08 in Q3 2022, beating estimates of $4.81 by $0.27.

On December 6, RBC Capital analyst Conor McNamara initiated coverage of Thermo Fisher Scientific Inc. (NYSE:TMO) with an Outperform rating and a $661 price target. The analyst sees the stock becoming a game-changer for future biopharma research and drug development by combining the company’s historical assets in life-science research with recent acquisitions in the CDMO, CRO, and diagnostics spaces.

Here is what Aristotle Atlantic Partners LLC had to say about Thermo Fisher Scientific Inc. (NYSE:TMO) in their Q3 2022 investor letter:

Thermo Fisher Scientific Inc. (NYSE:TMO) is considered one of the world’s leaders in serving science. The company makes and distributes analytical instruments, scientific equipment, consumables and other laboratory supplies. Thermo Fisher Scientific operates in four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics and Laboratory Product and Biopharma Services. We see Thermo Fisher Scientific as one of the leading management teams in our coverage both through solid execution and savvy Mergers & Acquisitions (M&A). The company is a diversified provider of research and discovery instruments, tools, consumables, and services, and offers a broad-based play on the increased Research & Development (R&D) spend from the biopharma industry. Thermo Fisher Scientific continues to see organic growth in the high single digits with acquisitions increasing their overall portfolio composition and gaining market share.”

Follow Thermo Fisher Scientific Inc. (NYSE:TMO)